Enzyme Inhibition in Drug Discovery and Development: The Good and the BadISBN: 978-0-470-28174-1
Hardcover
876 pages
January 2010
|
Chuang Lu, PhD, is the Associate Director in the Drug Safety
and Disposition Department of Millennium Pharmaceuticals. His
current research interests include drug-metabolizing enzymes,
drug–drug interaction, and in vitro–in vivo
correlation.
Albert P. Li, PhD, is the President and CEO of In Vitro ADMET Laboratories, LLC and Advanced Pharmaceutical Sciences, Inc., and the cofounder, Chairman, and CSO of the ADMET Group. His experience spans over twenty-five years in the drug development industry, with over 150 publications. He is the editor of several books, including Drug–Drug Interactions in Pharmaceutical Development, published by Wiley.